Y-Intercept (HK)’s AbCellera Biologics ABCL Stock Holding History

Y-Intercept (HK)’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$425K	Buy	+54,193	New	+$265K	0.01%	1360
2023 Q3	–	Sell	-106,606	Closed	-$689K	–	1003
2023 Q2	$689K	Buy	+106,606	New	+$728K	0.07%	429
2022 Q2	–	Sell	-46,355	Closed	-$452K	–	828
2022 Q1	$452K	Buy	+46,355	New	+$439K	0.1%	293

Other funds holding ABCL

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return

Allied Private Wealth Boca Raton, Florida $156M AUM